Data / Form D filings / Cosmos Health Inc.
Cosmos Health Inc.: Form D filings
Cosmos Health Inc., a pharmaceuticals company in Chicago, IL, filed 6 Form D notices with the SEC between 2017 and 2023. The latest, on July 27, 2023, reports $5.3 million sold of a $5.3 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 141 West Jackson Blvd, Suite 4236, Chicago, IL, 60604
- Phone
- (312) 536-3102
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1474167
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 27, 2023 | New notice | $5,250,000 | $5,250,000 | 3 | Jul 21, 2023 | sec.gov | |
| Jan 5, 2023 | Amendment | $32,525,680 | $32,525,680 | 0 | Dec 21, 2022 | sec.gov | |
| Dec 21, 2022 | New notice | $32,525,680 | $32,525,680 | 0 | Dec 21, 2022 | sec.gov | |
| Jun 5, 2019 | New notice | $1,500,000 | $1,500,000 | 1 | May 17, 2019 | sec.gov | |
| Sep 17, 2018 | New notice | $2,000,000 | $2,000,000 | 2 | Sep 4, 2018 | sec.gov | |
| Nov 29, 2017 | New notice | $3,000,000 | $3,000,000 | 2 | Nov 16, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anastasios Aslidis | Director | |
| Grigorios Siokas | Executive Officer, Director | |
| John J. Hoidas | Director | |
| Manfred J. Ziegler | Director | |
| Demetrios G. Demetriades | Director |
Every Form D from the week of Jul 24, 2023 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Cosmos Health Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.